Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 1, 2006, Pages 295-303

  Von Weymarn, Linda B ^a   Brown, Kathryn M ^a   Murphy, Sharon E ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE OXIDASE; COTININE; CYTOCHROME P450 2A13; CYTOCHROME P450 2A6; NICOTINE; NICOTINIC AGENT; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DIALYSIS; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INACTIVATION; ENZYME KINETICS; ENZYME METABOLISM; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; REACTION TIME;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CARBON MONOXIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESCHERICHIA COLI; HALF-LIFE; HEME; HUMANS; KINETICS; MIXED FUNCTION OXYGENASES; NADP; NICOTINE; NICOTINIC AGONISTS; RATS; SUBSTRATE SPECIFICITY;

EID: 29244464299     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.091306     Document Type: Article

References (39)

1. Bao Z, He XY, Ding X, Prabhu S, and Hong JY (2005) Metabolism of nicotine and cotinine by human cytochrome P450 2A13. Drug Metab Dispos 33:258-261.
2. Benowitz NL (1988) Pharmacological aspects of cigarette smoking and nicotine addiction. N Engl J Med 319:1318-1330.
3. Benowitz NL, Jacob P 3rd, Fong I, and Gupta S (1994) Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 268:296-303.
4. Brandänge S and Lindblom L (1979) The enzyme "aldehyde oxidase" is an iminium oxidase. Reaction with nicotine delta 1′(5′) iminium ion. Biochem Biophys Res Commun 91:991-996.
5. Davis RA and Curvall M (1999) Determination of nicotine and its metabolites in biological fluids: in vivo studies, in Analytical Determination of Nicotine and Related Compounds and Their Metabolites (Gorrod JW and Jacob P 3rd, eds) pp 583-643, Elsevier Science B.V., Amsterdam.
6. Denton TT, Zhang X, and Cashman JR (2004) Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. Biochem Pharmacol 67:751-756.
7. Fowler BA, Kleinow KM, Squibb KS, Lucier GW, and Hayes WA (1994) Organelles as tools in toxicology, in Principles and Methods of Toxicology (Wallace Hayes A ed) pp 1267-1268, Raven Press, New York.
8. Gorrod JW, Whittlesea CM, and Lam SP (1991) Trapping of reactive intermediates by incorporation of 14C-sodium cyanide during microsomal oxidation. Adv Exp Med Biol 283:657-664.
9. Gubisne-Haberle D, Hill W, Kazachkov M, Richardson JS, and Yu PH (2004) Protein cross-linkage induced by formaldehyde derived from semicarbazide- sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther 310:1125-1132.
10. Hanna IH, Teiber J, Kokones KL, and Hollenberg PF (1998) Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities. Arch Biochem Biophys 350:324-332.
11. Hecht SS, Hatsukami DK, Bonilla LE, and Hochlater JB (1999) Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl) butanoic acid in human urine: a substantial pathway of nicotine metabolism. Chem Res Toxicol 12:172-179.
12. Hecht SS, Hochalter JB, Villalta PW, and Murphy SE (2000) 2′-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: Formation of a lung carcinogen precursor. Proc Natl Acad Sci USA 97:12493-12497.
13. Hukkanen J, Jacob P 3rd, and Benowitz NL (2005) Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57:79-115.
14. Jalas JR, Hecht SS, and Murphy SE (2005) Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen. Chem Res Toxicol 18:95-110.
15. Kent UM, Yanev S, and Hollenberg PF (1999) Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate. Chem Res Toxicol 12:317-322.
16. Kitada M, Chiba K, Kamataki T, and Kitagawa H (1977) Inhibition by cyanide of drug oxidations in rat liver microsomes. Jpn J Pharmacol 27:601-608.
17. Koop DR and Hollenberg PF (1980) Kinetics of the hydroperoxide-dependent dealkylation reactions catalyzed by rabbit liver microsomal cytochrome P-450. J Biol Chem 255:9685-9692.
18. Masumoto H, Ohta S, and Hirobe M (1991) Application of chemical cytochrome P-450 model systems to studies on drug metabolism. IV. Mechanism of piperidine metabolism pathways via an iminium intermediate. Drug Metab Dispos 19:768-780.
19. McCoy GD, Howard PC, and DeMarco GJ (1986) Characterization of hamster liver nicotine metabolism I. Relative rates of microsomal C and N oxidation. Biochem Pharmacol 35:2767-2773.
20. Messina ES, Tyndale RF, and Sellers EM (1997) A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 282:1608-1614.
21. Metz B, Kersten GF, Hoogerhout P, Brugghe HF, Timmermans HA, de Jong A, Meiring H, ten Hove J, Hennink WE, Crommelin DJ, et al. (2004) Identification of formaldehyde-induced modifications in proteins: reactions with model peptides. J Biol Chem 279:6235-6243.
22. Murphy SE, Johnson LM, and Pullo DA (1999) Characterization of multiple products of cytochrome P450 2A6 catalyzed cotinine metabolism. Chem Res Toxicol 12:639-645.
23. Murphy SE, Raulinaitis V, and Brown KM (2005) Nicotine 5′-oxidation and methyl oxidation by P450 2A enzymes. Drug Metab Dispos 13:1166-1173.
24. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, and Kuroiwa Y (1996) Role of human cytochrome P4502A6 in c-oxidation of nicotine. Drug Metab Dispos 24:1212-1217.
25. Nguyen TL, Gruenke LD, and Castagnoli N (1979) Metabolic oxidation of nicotine to chemically reactive intermediates. J Med Chem 22:259-263.
26. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
27. Peterson LA, Trevor AJ, and Castagnoli N Jr (1987) Stereochemical studies on the cytochrome P-450 catalyzed oxidation of (S)-nicotine to the (S)-delta-1′,5′-iminium ion. J Med Chem 30:249-254.
28. 3H]nicotine to liver and lung microsomal macromolecules. Drug Metab Dispos 16:397-402.
29. Silverman RB (1996) Mechanism-based enzyme inactivators, in Contemporary Enzyme Kinetics and Mechanisms (Purich DL ed) pp 291-334, Academic Press, San Diego.
30. Soucek P (1999) Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization and preparation of polyclonal antibodies. Arch Biochem Biophys 370:190-200.
31. Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, and Ding X (2000) Human cytochrome P 450 CYP2A13: predominant expression in the respiratory tract and in high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074-5079.
32. Vickers S and Polsky SL (2000) The biotransformation of nitrogen containing xenobiotics to lactams. Curr Drug Metab 1:357-389.
33. von Weymarn LB, Blobaum AL, and Hollenberg PF (2004) The mechanism-based inactivation of P450 2B4 by tert-butyl 1-methyl-2-propynyl ether: structural determination of the adducts to the P450 heme. Arch Biochem Biophys 425:95-105.
34. von Weymarn LB, Felicia ND, Ding X, and Murphy SE (1999) N-Nitrosobenzylmethylamine α-hydroxylation and coumarin 7-hydroxylation by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes. Chem Res Toxicol 12:1254-1261.
35. von Weymarn LB, Zhang QY, Ding X, and Hollenberg PF (2005) Effects of 8-methoxypsoralen on cytochrome P450 2A13. Carcinogenesis 26:621-629.
36. Williams DE, Shigenaga MK, and Castagnoli N (1990) The role of cytochromes P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung. Drug Metab Dispos 18:418-428.
37. Wong HL, Murphy SE, and Hecht SS (2005a) Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N′-nitrosonornicotine enantiomers, N-nitrosopiperidine and N-nitrosopyrrolidine. Chem Res Toxicol 18:61-69.
38. Wong HL, Zhang X, Zhang QY, Gu J, Ding X, Hecht SS, and Murphy SE (2005b) Metabolic activation of the tobacco carcinogen 4-(methylnitrosamino)-(3- pyridyl)-1-butanone by cytochrome P450 2A13 in human fetal nasal microsomes. Chem Res Toxicol 18:913-918.
39. Yamazaki H, Inoue K, Hashimoto M, and Shimada T (1999) Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol 73:65-70.